Biomarker Responses During Mid-term Mechanical Cardiac Support in Children

Journal of Heart and Lung Transplantation

Volumn 27, Issue 2, 2008, Pages 150-157

  Heise, Grit ^a   Lemmer, Julia ^a   Weng, Yuguo ^a   Hübler, Michael ^a   Alexi Meskishvili, Vladimir ^a   Böttcher, Wolfgang ^a   Hetzer, Roland ^a   Berger, Felix ^a   Stiller, Brigitte ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ADOLESCENT; ARTICLE; ASSISTED CIRCULATION; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; WEANING;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EQUIPMENT FAILURE; FEMALE; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; WAITING LISTS;

EID: 38949097785     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.11.564     Document Type: Article

References (46)

1. Stiller B., Weng Y., Hübler M., et al. Pneumatic pulsatile ventricular assist devices in children under 1 year of age. Eur J Cardiothorac Surg 28 (2005) 234-239
2. Hetzer R., Loebe M., Weng Y., Alexi-Meskhishvili V., and Stiller B. Pulsatile pediatric ventricular assist devices: current results for bridge to transplantation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2 (1999) 157-176
3. Merkle F., Boettcher W., Stiller B., and Hetzer R. Pulsatile mechanical cardiac assistance in pediatric patients with the Berlin heart ventricular assist device. J Extra-Corp Technol 35 (2003) 115-120
4. Hetzer R., Potapov E.V., Stiller B., et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg 82 (2006) 917-925
5. Milting H., El-Banayosy A., Kassner A., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transplant 20 (2001) 949-955
6. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
7. Hulsmann M., Berger R., Mortl D., et al. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Eur J Heart Fail 7 (2005) 552-556
8. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
9. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide?. How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
10. Weber M., Arnold R., Rau M., et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 26 (2005) 1023-1030
11. Bruch C., Reinecke H., Stypmann J., et al. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure. J Heart Lung Transplant 25 (2006) 1135-1141
12. Thompson L.O., Skrabal C.A., Loebe M., et al. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res 123 (2005) 25-32
13. Morawietz H., Szibor M., Goettsch W., et al. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation 102 suppl (2000) III-188-III-193
14. Mir T.S., Marohn S., Laer S., Eiselt M., Grollmus O., and Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110 (2002) e76
15. Westerlind A., Wahlander H., Lindstedt G., Lundberg P.A., and Holmgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93 (2004) 340-345
16. Nasser N., Bar-Oz B., and Nir A. Natriuretic peptides and heart disease in infants and children. J Pediatr 147 (2005) 248-253
17. Holmgren D., Westerlind A., Lundberg P.A., and Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imag 25 (2005) 263-269
18. Holmstrom H., Hall C., Stokke T.O., and Thaulow E. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age. Scand J Clin Lab Invest 60 (2000) 149-159
19. Nir A., and Nasser N. Clinical value of NT-proBNP and BNP in pediatric cardiology. J Card Fail 11 suppl (2005) S76-S80
20. Suttner S.W., and Boldt J. Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 10 (2004) 336-341
21. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
22. Mir T.S., Flato M., Falkenberg J., et al. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 27 (2006) 73-77
23. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
24. Rauh M., and Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 49 (2003) 1563-1564
25. Nir A., Bar-Oz B., Perles Z., Brooks R., Korach A., and Rein A.J. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 93 (2004) 603-607
26. Karabulut A., Kaplan A., Aslan C., et al. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure. Acta Cardiol 60 (2005) 631-638
27. Koch A., Kitzsteiner T., Zink S., Cesnjevar R., and Singer H. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int J Cardiol 114 (2007) 339-344
28. Vesely D.L. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression. IUBMB Life 53 (2002) 153-159
29. Yoshibayashi M., Saito Y., and Nakao K. Brain natriuretic peptide versus atrial natriuretic peptide-physiological and pathophysiological significance in children and adults: a review. Eur J Endocrinol 135 (1996) 265-268
30. Ala-Kopsala M., Magga J., Peuhkurinen K., et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588
31. Stiller B., Lemmer J., Merkle F., et al. Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device. Intensive Care Med 30 (2004) 1814-1820
32. Stiller B., Dahnert I., Weng Y.G., et al. Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 82 (1999) 237-240
33. Stiller B., Hetzer R., Weng Y., et al. Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant 22 (2003) 1201-1208
34. Hetzer R., and Stiller B. Technology insight: use of ventricular assist devices in children. Nat Clin Pract Cardiovasc Med 3 (2006) 377-386
35. Morgenthaler N.G., Struck J., Thomas B., and Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50 (2004) 234-236
36. Rothenburger M., Wichter T., Schmid C., et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 23 (2004) 1189-1197
37. Sodian R., Loebe M., Schmitt C., et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 38 (2001) 1942-1949
38. Rothenburger M., Stypmann J., Bruch C., et al. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function. J Heart Lung Transplant 25 (2006) 596-602
39. Dandel M., Weng Y., Siniawski H., et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112 (2005) I-37-I-45
40. Galasko G.I., Barnes S.C., Collinson P., Lahiri A., and Senior R. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?. Eur Heart J 27 (2006) 193-200
41. Kemperman H., van den Berg M., Kirkels H., and de Jonge N. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 50 (2004) 1670-1672
42. Kuhn M., Voss M., Mitko D., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 64 (2004) 308-314
43. Miyagawa S., Sawa Y., Fukushima N., et al. Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support. J Heart Lung Transplant 20 (2001) 1181-1187
44. Potapov E.V., Hennig F., Wagner F.D., et al. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. Eur J Cardiothorac Surg 27 (2005) 899-905
45. Bruggink A.H., de Jonge N., van Oosterhout M.F., et al. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant 25 (2006) 174-180
46. Costello J.M., Backer C.L., Checchia P.A., et al. Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. J Thorac Cardiovasc Surg 130 (2005) 822-829